Brief: Biomerica Receives Mhra Registration For Hp+Detect™, Allowing Commercial Sales In Great Britain
05/03/2026 13:20
March 5 (Reuters) - Biomerica Inc BMRA.O: BIOMERICA RECEIVES MHRA REGISTRATION FOR HP+DETECT™, ALLOWING COMMERCIAL SALES IN GREAT BRITAIN Source text: ID:nGNX2xlzQk Further company coverage: BMRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biomerica
See all newsDiagnostics firm Biomerica's Q1 revenue drops on lower clinical lab orders
Brief: Biomerica May Offer Up To $250 Million Of Common Stock, Preferred Stock, Debt Securities, & Warrants
Brief: Biomerica Lands $1.75 Million CDMO Master Services Agreement For IVD Diagnostic Development
Biomerica's Q3 revenue falls, net loss widens on lower manufacturing sales
Brief: Biomerica Q3 Net Income USD -1.31 Million